Conversion of epoxyeicosatrienoic acids (EETs) to chain-shortened epoxy fatty acids by human skin fibroblasts

Journal of Lipid Research

Volumn 41, Issue 1, 2000, Pages 66-74

  Fang, Xiang ^a   Kaduce, Terry L ^a   VanRollins, Mike ^a   Weintraub, Neal L ^a   Spector, Arthur A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

oxidation; Arachidonic acid; Cytochrome 1'450 epoxygenase; Eicosanoids; Peroxisomes

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ACYL COENZYME A OXIDASE; ARACHIDONIC ACID; CYTOCHROME P450; EPOXIDE; EPOXYICOSATRIENOIC ACID; ICOSATRIENOIC ACID; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; MASS SPECTROMETRY; PEROXISOME; PRIORITY JOURNAL; SKIN FIBROBLAST; ZELLWEGER SYNDROME;

CELLS, CULTURED; CULTURE MEDIA; EPOXY COMPOUNDS; FATTY ACIDS, UNSATURATED; FIBROBLASTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MUTATION; SKIN;

EID: 0033964243     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Oliw, E. H., J. Bylund, and C. Herman. 1996. Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450. Lipids. 31: 1003-1021.
2. Fitzpatrick, F. A., and R. C. Murphy. 1988. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. Pharmacol. Rev. 40: 229-241.
3. McGiff, J. C. 1991. Cytochrome P450 metabolism of arachidonic acid, Annu. Rev. Pharmacol. Toxicol. 31: 339-369.
4. Capdevila, J. H., J. R. Falck, and R. W. Estabrook. 1992. Cytochrome P450 and the arachidonic cascade. FASEB J. 6: 731-736.
5. Harder, D. R., W. B. Campbell, and R. J. Roman. 1995. Role of cytochrome P450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 32: 79-92.
6. + channel in vascular smooth muscles by cytochromo P450 metabolites of arachidonic acid. Eur. J. Pharmacol. 230: 215-221.
7. Hecker, M., A. T. Bara, J. Bauersachs, and R. Busse. 1994. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. (Lond). 481: 407-414.
8. +-channel activity. Am. J. Physiol. 270: F822-F832.
9. Campbell, W. B., Gebremedhin, P. F. Pratt, and D. R. Harder. 1996. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78: 415-423.
10. Gebremedhin, D., Y-H. Ma, J. R. Falck, R. J. Roman, M. VanRollins, and D. R. Harder. 1992. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebtal arterial smooth muscle. Am. J. Physiol. 263: H519-H525.
11. Bauersachs, J., M. Hecker, and R. Busse. 1994. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br. J. Pharmacol. 113: 1548-1553.
12. Nagao, T., and P. M. Vanhoutte. 1992. Hyperpolarization as a mechanism for endothelium-dependent relaxations of the porcine coronary artery. J. Physiol. (Lond). 445: 355-367.
13. Garland, C. J., F. Plane, B. K. Kemp, and T. M. Cocks. 1995. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci. 16: 23-30.
14. 2+ entry. J. Physiol. (Lond.) 482: 259-274.
15. Rzigalinski, B. A., K. A. Willoughby, S. W. Hoffman, J. R. Falck, and K. F. Ellis. 1999. Calcium influx factor, further evidence it is 5,6-epoxyeicosatrienoic acid. J. Biol. Chem. 274: 175-182.
16. F. A. Fitzpatrick, M. D. Ennis, M. E. Baze, M. A. Wynalda, J. E. McGee and W. F. Liggett. 1986. Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry. J. Biol. Chem. 261: 15334-15338.
17. 2 production in vascular smooth muscle cells. Am. J. Physiol. 275: H2113-H2121.
18. Hoebel B. G., and W. F. Graier. 1998. 11,12-Epoxyeicosatrienoic acid stimulates tyrosine kinase activity in porcine aortic endothelial cells. Eur. J. Pharmacol. 346: 115-117.
19. Pritchard, K. A., Jr., P. Y-K. Wong, and M. B. Stemmerman. 1990. Atherogenic concentrations of low-density lipoproteins enhance endothelial generation of epoxyeicoatrienoic products. Am. J. Pathol. 136: 1383-1391.
20. Pritchard, K. A., Jr., R. R. Tota, M. B. Stemmerman, and P. Y-K. Wong. 1990. 14,15-Epoxyeicosatrienoic acid promotes endothelial cell dependent adhesion of human monocytic tumor U937 cells. Biochem. Biophys. Res. Commun. 167: 137-142.
21. Karara, A., E. Dishman, J. R. Falck, and J. H. Capdevila. 1991. Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J. Biol. Chem. 266: 7561-7569.
22. Bernstrom, K., K. Kayganich, R. C. Murphy, and F. A. Fitzpatrick. 1992. Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids. J. Biol. Chem. 267: 3686-3690.
23. VanRollins, M., T. L. Kadue, H. R. Knapp, A. A. Spector. 1993. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J. Lipid Res. 34: 1931-1942.
24. Zeldin, D. C., J. Kobayashi, J. R. Falck, B. D. Hammock, J. R. Snapper, and J. H. Capdevila. 1993. Regio- and entiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J. Biol. Chem. 268: 6402-6407.
25. Zeldin, D. C., S. Wei, J. R. Falck, B. S. Winder, B. D. Hammock, J. R. Snapper, and J. H. Capdevila. 1995. Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. Arch. Biochem. Biophys. 316: 443-451.
26. Fang, X., M. VanRollins, T. L. Kaduce, and A. A. Spector. 1995. Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells. J. Lipid Res. 36: 1236-1246.
27. Fang, X., T. L. Kaduce, N. L. Weintraub, M. VanRollins, and A. A. Spector. 1996. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle. Circ. Res. 79: 784-793.
28. Gordon, J. A., P. H. Figard, and A. A. Spector. 1990. HETE metabolism in cultured human skin fibroblasts: evidence for peroxisomal β-oxidation. J. Clin. Invest. 85: 1173-1181.
29. Gordon, J. A., S. K. Heller, T. L. Kaduce, and A. A. Spector. 1994. Formation and release of a peroxisome-dependent arachidonic acid metabolic by human skin fibroblasts. J. Biol. Chem. 269: 4103-4109.
30. Gordon, J. A., S. K. Heller, W. J. Rhead, P. A. Watkins, and A. A. Spector. 1995. Formation of a novel arachidonic acid metabolite in peroxisomes, Prostagl. Leukot. Essent. Fatty Acids. 52: 77-81.
31. VanRollins, M. 1990. Synthesis and characterization of cytochrome P-450 epoxygenase metabolites of eicosapentaenoic acid. Lipids. 25: 481-190.
32. Kurtz, D. M., P. Rinaldo, W. J. Rhead, L. Tian, D. S. Millington, J. Voekley, D. A. Hamm, A. E. Brix, J. R. Lindsey, C. A. Pinkert, W. E. O'Brien, and P. A. Wood. 1998. Targeted disruption of mouse long-chain acyl CoA dehydrogenase gene reveals crucial role for fatty acid oxidation. Proc. Natl. Acad. Sci. USA. 95: 15592-15597.
33. Spector, A. A., D. E. Williard, T. L. Kaduce, and R. L. Widstrom. 1999. Role of peroxisomal oxidation in the conversion of arachidonic acid to eicosatrienoic acid in human skin fibroblasts. Prostagl. Leukot. Essent. Fatty. Acids. 60: 377-382.
34. Williard, D. E., T. L. Kaduce, S. D. Harmon, and A. A. Spector. 1998. Conversion ot eicosapentaenoic acid to chain-shortened omega-3 fatty acid metabolites by peroxisomal oxidation. J. Lipid Res. 39: 978-986.
35. VanRollins, M., and H. R. Knapp. 1995. Identification of arachidonate epoxides/diols by capillary chromatography-mass spectrometry. J. Lipid Res. 36: 952-966.
36. Guenthner, T. M. 1986. Selective inhibition and selective induction of multiple microsomal epoxide hydrolases. Biochem. Pharmacol. 35: 839-845.
37. Pahan, K., B. T. Smith, and I. Singh. 1996. Epoxide hydrolase in human and rat peroxisomes: implications for disorders of peroxisomal biogenesis. J. Lipid Res. 37: 159-167.
38. Shen, X-Y., P. H. Figard, T. L. Kaduce, and A. A. Spector. 1988. Conversion of 15-hydroxyeicosatetraenoic acid to 11-hydroxyhexadecatrienoic acid by endothelial cells. Biochemistry. 27: 996-1004.
39. Fang, X., T. L. Kaduce, and A. A. Spector. 1999. 13-(S)-Hydroxyoctadecadienoic acid (13-HODE) incorporation and conversion to novel products by endothelial cells. J. Lipid Res. 40: 699-707.
40. Kunau, W-H., V. Dommes, and H. Schulz. 1995. β-Oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of progress. Prog. Lipid Res. 34: 267-342.
41. 2,4-dienolCoA isomerase. J. Biol. Chem. 270: 13771-13776.
42. Proctor, K. G., J. R. Falck, and J. Capdevila. 1987. Intestinal vasodilatation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450 monooxygenase. Circ. Res. 60: 50-59.
43. Carroll, M. A., M. Schwartzman, M. Capdevila, J. Falck, and J. C. McGiff. 1987. Vasoactivity of arachidonic acid epoxides. Eur. J. Pharmacol. 138: 281-283.
44. Pfister, S. L., J. R. Falck, and W. B. Campbell. 1991. Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. Am. J. Physiol. 261: H843-H852.
45. Weintraub, N. L., X. Fang, T. L. Kaduce, M. VanRollins, P. Chatterjee, and A. A. Spector. 1997. Potentiation of endothelium-dependent relaxation by eicosatrienoic acids. Circ. Res. 81: 258-267.
46. Olman, C. L., N. L. Weintraub, M. VanRollins, and K. C. Dellsperger. 1998. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ. Res. 83: 932-939.